CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis C$0.30 -0.01 (-1.61%) (As of 12/24/2024 01:21 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsInsider Trades About DIAGNOS Stock (CVE:ADK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DIAGNOS alerts:Sign Up Key Stats Today's RangeC$0.30▼C$0.3150-Day RangeC$0.26▼C$0.3552-Week RangeC$0.23▼C$0.43Volume65,800 shsAverage Volume95,162 shsMarket CapitalizationC$24.84 millionP/E RatioN/ADividend Yield0.29%Price TargetN/AConsensus RatingStrong Buy Company OverviewDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Read More… Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address ADK Stock News HeadlinesDIAGNOS Second Quarter 2025 Earnings: Revenues DisappointNovember 23, 2024 | finance.yahoo.comDIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock ExchangeNovember 12, 2024 | finance.yahoo.comTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… December 26, 2024 | Crypto 101 Media (Ad)DIAGNOS Inc.: DIAGNOS Announces Voting Results of Meeting of ShareholdersOctober 1, 2024 | finanznachrichten.deADK:CA DIAGNOS Inc.September 21, 2024 | seekingalpha.comDIAGNOS First Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagAugust 23, 2024 | finance.yahoo.comGot $1,000? 2 Stocks to Buy Now While They’re on SaleFebruary 23, 2024 | ca.finance.yahoo.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | finance.yahoo.comSee More Headlines ADK Stock Analysis - Frequently Asked Questions How have ADK shares performed this year? DIAGNOS's stock was trading at C$0.41 on January 1st, 2024. Since then, ADK shares have decreased by 24.7% and is now trading at C$0.31. View the best growth stocks for 2024 here. How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ADK CUSIPN/A CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-3,090,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-134.33% Debt Debt-to-Equity Ratio245.28 Current Ratio0.39 Quick Ratio0.68 Sales & Book Value Annual SalesC$577,486.00 Price / Sales43.01 Cash FlowC$0.01 per share Price / Cash Flow60.00 Book ValueC($0.03) per share Price / Book-10.17Miscellaneous Outstanding Shares81,440,000Free FloatN/AMarket CapC$24.84 million OptionableNot Optionable Beta-0.44 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (CVE:ADK) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.